Literature DB >> 2176309

Effects of cortisol treatment on brain and adrenal corticotropin-releasing hormone (CRH) content and other parameters regulated by CRH.

G Bagdy1, A E Calogero, K Szemeredi, G P Chrousos, P W Gold.   

Abstract

Corticotropin-releasing hormone (CRH) has been found in both hypothalamic and extrahypothalamic sites of the brain and also in the adrenal medulla. To study the timing and location of delayed glucocorticoid action in rats, we measured the effects of 2-day and 7-day cortisol treatment on immunoreactive CRH concentrations in hypothalamus, cerebral cortex, hippocampus, cerebellum, and adrenal gland. The activity of the hypothalamo-pituitary-adrenal (HPA) axis and the sympathoadrenal system were also measured. Studies were carried out both in the afternoon and/or in the morning, to get information about possible circadian changes. CRH contents were not changed in any brain areas studied, except there was a trend of decrease in the hypothalamus compared to vehicle in the afternoon due to the lack of circadian increase after 7-day cortisol treatment. Pituitary ACTH content decreased significantly after 7-day treatment, while beta-endorphin did not. Plasma levels of ACTH, corticosterone, norepinephrine and epinephrine and adrenal ACTH and beta-endorphin contents decreased after 2-day, adrenal CRH content after 7-day treatment with cortisol. Our findings suggest, that chronic cortisol treatment inhibits the circadian activation of the HPA axis at all levels but has variable effects on baseline measures because it causes different changes in release and synthesis at different sites.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176309     DOI: 10.1016/0167-0115(90)90111-9

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  2 in total

1.  Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat.

Authors:  A E Calogero; C Liapi; G P Chrousos
Journal:  J Endocrinol Invest       Date:  1991-04       Impact factor: 4.256

2.  Short treatment with antalarmin alters adrenal gland receptors in the rat model of endometriosis.

Authors:  Annelyn Torres-Reverón; Maahrose Rana; Varesh Gorabi; Leslie L Rivera-Lopez; Caroline B Appleyard
Journal:  PLoS One       Date:  2020-01-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.